These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33030804)

  • 1. Association of the Non-Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross-sectional study in China.
    Fan N; Ding X; Zhen Q; Gu L; Zhang A; Shen T; Wang Y; Peng Y
    J Diabetes Investig; 2021 Jun; 12(6):1035-1041. PubMed ID: 33030804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease.
    Turan Y
    Angiology; 2020 Jan; 71(1):77-82. PubMed ID: 31018673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease.
    Alkayyali T; Qutranji L; Kaya E; Bakir A; Yilmaz Y
    Acta Diabetol; 2020 May; 57(5):613-618. PubMed ID: 31897769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy.
    Acar B; Celikyurt U; Agacdiken A; Vural A
    Pacing Clin Electrophysiol; 2023 Mar; 46(3):251-257. PubMed ID: 36593653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
    Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
    Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Liver Fibrosis Indices as Indicators of Microvascular and Macrovascular Complications in Type 2 Diabetes.
    Erman H; Boyuk B; Arslan S; Akin S; Keskin Ö
    Metab Syndr Relat Disord; 2024 Oct; 22(8):619-625. PubMed ID: 38836748
    [No Abstract]   [Full Text] [Related]  

  • 9. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease.
    Singh A; Gosai F; Siddiqui MT; Gupta M; Lopez R; Lawitz E; Poordad F; Carey W; McCullough A; Alkhouri N
    J Clin Gastroenterol; 2020; 54(10):891-897. PubMed ID: 32168133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.
    Hara T; Uemoto R; Sekine A; Mitsui Y; Masuda S; Yamagami H; Kurahashi K; Yoshida S; Otoda T; Yuasa T; Kuroda A; Ikeda Y; Endo I; Honda S; Yoshimoto K; Kondo A; Tamaki T; Matsumoto T; Matsuhisa M; Abe M; Aihara KI
    J Atheroscler Thromb; 2023 Aug; 30(8):871-883. PubMed ID: 36244745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
    Ciardullo S; Muraca E; Perra S; Bianconi E; Zerbini F; Oltolini A; Cannistraci R; Parmeggiani P; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
    Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
    Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study.
    Hara M; Tanaka S; Torisu K; Matsukuma Y; Tsuchimoto A; Tokumoto M; Ooboshi H; Nakano T; Tsuruya K; Kitazono T
    Clin Exp Nephrol; 2021 Aug; 25(8):822-834. PubMed ID: 33856608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD.
    Xun YH; Guo JC; Lou GQ; Jiang YM; Zhuang ZJ; Zhu MF; Luo Y; Ma XJ; Liu J; Bian DX; Shi JP
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):643-9. PubMed ID: 24837195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between Liver Fibrosis Scores and Ascending Aortic Dilatation.
    Duman H; Durak H; İpek E; Duman H; Şahin MA
    J Gastrointestin Liver Dis; 2024 Sep; 33(3):348-354. PubMed ID: 39348587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Liver Fibrosis Score to Detect Advanced Fibrosis in Diabetics with Nonalcoholic Fatty Liver Disease.
    Singh A; Garg R; Lopez R; Alkhouri N
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e624-e626. PubMed ID: 33434655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes.
    Aller de la Fuente R; Mora Cuadrado N; Tafur C; López Gómez JJ; Gómez de la Cuesta S; García Sánchez MC; Antolin Melero B; de Luis Román DA
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):354-360. PubMed ID: 29477355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of non-invasive liver fibrosis scores for mortality and complications development in individuals with type 2 diabetes.
    Leite NC; Cardoso CRL; Salles GF
    J Diabetes Complications; 2021 May; 35(5):107879. PubMed ID: 33573891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
    Ampuero J; Pais R; Aller R; Gallego-Durán R; Crespo J; García-Monzón C; Boursier J; Vilar E; Petta S; Zheng MH; Escudero D; Calleja JL; Aspichueta P; Diago M; Rosales JM; Caballería J; Gómez-Camarero J; Lo Iacono O; Benlloch S; Albillos A; Turnes J; Banales JM; Ratziu V; Romero-Gómez M;
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):216-225.e5. PubMed ID: 31195161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels.
    Dludla PV; Essop MF; Gabuza KB; Muller CJF; Louw J; Johnson R
    Heart Vessels; 2017 Aug; 32(8):1025-1031. PubMed ID: 28393273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.